US 9260414
Inhibitors of hepatitic C virus
granted A61KA61K31/496A61K45/06
Quick answer
US patent 9260414 (Inhibitors of hepatitic C virus) held by Theravance Biopharma R&D IP, LLC expires Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Feb 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/496, A61K45/06, A61P, A61P1/16